The efficacy of a serum screening service for neural-tube defects: the South Wales experience

Abstract

Serum-alpha-fetoprotein (AFP) levels were measured in more than 15 000 pregnant women in an investigation designed to examine the operational issues entailed in a large-scale population screening programme for antenatal detection of neural-tube defects. The proportion of open neural-tube defects (ONTD) terminated as a result of serum screening was 56.1% (66.6% for anencephaly and 40.7% for open spina bifida). The principle causes of poor efficacy were: failure of pregnant women to undergo screening (18.2% of ONTD were not screened); failure of the screening test to detect ONTD (20.4% of those screened were below the 90th centile); decisions against termination of detected ONTD (14% of ONTD detected by serum AFP were not terminated). Given present practices and knowledge it is doubtful whether overall efficacy levels above 65% for open spina bifida can be achieved under normal service conditions. The establishment of a regional or national screening programme on grounds of clinical efficacy alone may be premature. The decision would seem to hinge principally around a careful consideration of the economic issues.

KIE: In 1976, the Department of Health and Social Security provided funding to the South Wales Anencephaly and Spina Bifida Screening Group to examine the operational issues entailed in a large-scale screening program for prenatal detection of neural tube defects. The results of the study of serum alpha-fetoprotein levels in 15,000 pregnant women are reported. It is concluded that the establishment of a regional or national screening program on grounds of clinical efficacy alone is probably premature.